Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of Quetiapine to Reduce Post Concussive Syndrome Polypharmacy

NCT06333990 is registered in ClinicalTrials.gov with Foundation for Advancing Veterans' Health Research as lead sponsor.

NCT NCT06333990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06333990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of Quetiapine to Reduce Post Concussive Syndrome Polypharmacy
Lead sponsor
Foundation for Advancing Veterans' Health Research
Phase
Phase 3
Overall status
Recruiting
Start date
July 9, 2024
Completion date
June 30, 2028
Enrollment
146 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mild traumatic brain injury